EUVIMEDScopri EUVIMED
Open access · CC BY 4.0

Transglutaminase 2 knockout mice are protected from bleomycin‐induced lung fibrosis with preserved lung function and reduced metabolic derangements

Margaret A T Freeberg iD, Thomas H Thatcher iD, Sarah V Camus, Linghong Huang, John Atkinson, Wade Narrow, Jeannie Haak, Andrew M Dylag iD, L Ashley Cowart, Timothy S Johnson, Patricia J Sime iD

Physiological Reports · 2024

DOI: 10.14814/phy2.16012 ↗

At a glance

Journal article in Physiological Reports, 2024. Written by Margaret A T Freeberg and 10 co-authors. Institution: Division of Pulmonary Disease and Critical Care Medicine, Virginia Commonwealth University, Richmond, Virginia, USA. Major MEDLINE topics: Bleomycin, Lung, Protein Glutamine gamma Glutamyltransferase 2, Pulmonary Fibrosis. Cited 7 times so far (Crossref); 31 references. The full text is freely available (open access, CC BY 4.0). Funded by: NHLBI NIH HHS, HHS | NIH | NHLBI | NHLBI Division of Intramural Research (DIR), UCB Pharma SA.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Pulmonary fibrosis is an interstitial scarring disease of the lung characterized by poor prognosis and limited treatment options. Tissue transglutaminase 2 (TG2) is believed to promote lung fibrosis by crosslinking extracellular matrix components and activating latent TGFβ. This study assessed physiologic pulmonary function and metabolic alterations in the mouse bleomycin model with TG2 genetic deletion. TG2‐deficient mice demonstrated attenuated the fibrosis and preservation of lung function, with significant reduction in elastance and increases in compliance and inspiratory capacity compared to control mice treated with bleomycin. Bleomycin induced metabolic changes in the mouse lung that were consistent with increased aerobic glycolysis, including increased expression of lactate dehydrogenase A and increased production of lactate, as well as increased glutamine, glutamate, and aspartate. TG2‐deficient mice treated with bleomycin exhibited similar metabolic changes but with reduced magnitude. Our results demonstrate that TG2 is required for a typical fibrosis response to injury. In the absence of TG2, the fibrotic response is biochemically similar to wild‐type, but lesions are smaller and lung function is preserved. We also show for the first time that profibrotic pathways of tissue stiffening and metabolic reprogramming are interconnected, and that metabolic disruptions in fibrosis go beyond glycolysis.

Subjects

MeSH terms (MEDLINE)

BleomycinLungProtein Glutamine gamma Glutamyltransferase 2Pulmonary FibrosisTransglutaminasesAnimalsMaleMiceGlycolysisGTP-Binding ProteinsMice, Inbred C57BLMice, Knockout

Author keywords

metabolismmetabolomicspulmonary fibrosistransglutaminase

Substances

BleomycinGTP-Binding ProteinsProtein Glutamine gamma Glutamyltransferase 2Transglutaminases

Authors and institutions

  • Division of Pulmonary Disease and Critical Care Medicine, Virginia Commonwealth University, Richmond, Virginia, USA.
  • Division of Pulmonary and Critical Care Medicine, University of Rochester, Rochester, New York, USA.
  • UCB Pharma SA, Slough, Berkshire, UK.
  • Department of Pediatrics, Division of Neonatology, University of Rochester Medical Center, Rochester, New York, USA.
  • Department of Biochemistry and Molecular Biology, Virginia Commonwealth University, Richmond, Virginia, USA.

ORCID profiles: Margaret A T Freeberg, Thomas H Thatcher, Andrew M Dylag, Patricia J Sime

Funding

  • NHLBI NIH HHS
  • HHS | NIH | NHLBI | NHLBI Division of Intramural Research (DIR)
  • UCB Pharma SA
  • American Lung Association (ALA)
  • HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI)
  • Pulmonary Fibrosis Foundation (PFF)
  • NCI NIH HHS
  • National Heart, Lung, and Blood Institute

Cite

APA

Freeberg, M. A. T., Thatcher, T. H., Camus, S. V., Huang, L., Atkinson, J., Narrow, W., Haak, J., Dylag, A. M., Cowart, L. A., Johnson, T. S., & Sime, P. J. (2024). Transglutaminase 2 knockout mice are protected from bleomycin‐induced lung fibrosis with preserved lung function and reduced metabolic derangements. Physiological Reports. https://doi.org/10.14814/phy2.16012

Vancouver

Freeberg MAT, Thatcher TH, Camus SV, Huang L, Atkinson J, Narrow W, et al. Transglutaminase 2 knockout mice are protected from bleomycin‐induced lung fibrosis with preserved lung function and reduced metabolic derangements. Physiological Reports. 2024. doi:10.14814/phy2.16012

BibTeX
@article{Freeberg2024,
  author = {Freeberg, Margaret A T and Thatcher, Thomas H and Camus, Sarah V and Huang, Linghong and Atkinson, John and Narrow, Wade and Haak, Jeannie and Dylag, Andrew M and Cowart, L Ashley and Johnson, Timothy S and Sime, Patricia J},
  title = {Transglutaminase 2 knockout mice are protected from bleomycin‐induced lung fibrosis with preserved lung function and reduced metabolic derangements},
  journal = {Physiological Reports},
  year = {2024},
  doi = {10.14814/phy2.16012}
}
Start for free →